CHRS
Coherus Oncology, Inc. Common Stock
$1.76
6.67%
+0.11
Notify me if price changes either direction
Buy CHRS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
263.1M
Enterprise value
62.1M
Trailing PE
3
Forward PE
-3.3673468
PEG Ratio
0.012272727272727
Enterprise to EBITDA
-0.778
Enterprise to revenue
0.224
Price to book MRQ
2.1854305
Price to sales TTM
0.8880169
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
277.7M
EBITDA
-79791000
Diluted EPS TTM
0.55
Total Cash (MRQ)
191.7M
Current ratio (MRQ)
1.238
Operating Cash Flow (TTM)
-90189000
CHRS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
